EIF5A2 and cancer: EIF5A2, which has been implicated as an oncogene that enhances chemoresistance in several cancers, harbored a potential miR-9 binding site (Figure 4A). As shown in Figure 4 B, the “seed sequence” of miR-9 matched precisely with the 3'-UTR of EIF5A2.